Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study

被引：0
|
作者：
Zhang, Yong
Che, Shaomin
Chen, Nanzheng
Li, Xinju
Fu, Junke
Yu, Chenao
Wang, Tianren
Liang, Runjia
Xu, Haozhen
Wu, Qifei
Jia, Zhuoqi
Zhu, Cailin
Gong, Tuotuo
Li, Haijun
Zhang, Boxiang
Hu, Yunyun
Liu, Yaqi
机构：
[1] Xi An Jiao Tong Univ, Dept Thorac Surg, Affiliated Hosp 1, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Radiat Oncol, Affiliated Hosp 1, Xian, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16090
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant tislelizumab combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Single arm phase II study
    Jin, Peng
    Gao, Yong Sheng
    Fu, Zheng
    Yang, Wen Feng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Phase-II study of toripalimab combined with neoadjuvant chemotherapy for the treatment of resectable esophageal squamous cell carcinoma.
    Liu, Delin
    Zhang, Qin
    Zhu, Jinghua
    Qian, Ting
    Yin, Rong
    Fan, Zhaohui
    Jiang, Feng
    Li, Houhuai
    Lu, Jianwei
    Cao, Guochun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study
    Zhuo, Na
    Qiu, Wei
    He, Jia
    Li, Li
    Wang, Qiang
    Yu, Shuangni
    Liu, Wei
    Zhao, Lin
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study
    Zhang, Y.
    Yuan, Y.
    Xu, Y.
    Tian, R.
    Liao, J.
    Zeng, X.
    Wang, Y.
    Liu, Y.
    Zhou, X.
    Peng, F.
    Zhou, L.
    Wang, H.
    Hou, W.
    Yu, M.
    Xiu, W.
    Huang, M.
    Zhang, X.
    Gong, Y.
    Lu, Y.
    Zou, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S865 - S865
  • [5] Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer (TD-NICE): A single arm, phase II study
    Yan, X.
    Zhao, J.
    Lei, J.
    Duan, H.
    Ni, Y.
    Zhou, Y.
    Wang, X.
    Qi, H.
    Liu, H.
    Tian, F.
    Lu, Q.
    Sun, J.
    Yang, E.
    Zhong, D.
    Wang, T.
    Huang, L.
    Wang, J.
    Jiang, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S1442 - S1442
  • [6] Neoadjuvant Tislelizumab Combined with Chemoradiotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Study and Exploration of Immunologic Features
    Jin, P.
    Gao, Y.
    Fu, Z.
    Yang, W.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E454 - E454
  • [7] Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma
    Okamura, A.
    Watanabe, M.
    Mine, S.
    Kurogochi, T.
    Yamashita, K.
    Hayami, M.
    Imamura, Y.
    Ogura, M.
    Ichimura, T.
    Takahari, D.
    Chin, K.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 8
  • [8] Phase II study of neoadjuvant chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel for resectable esophageal squamous cell carcinoma.
    Matsuda, Satoru
    Fukuoka, Shota
    Tsushima, Takahiro
    Watanabe, Akinori
    Kadowaki, Shigenori
    Takeuchi, Hiroya
    Hosokawa, Ayumu
    Kubota, Yohei
    Yoshii, Takako
    Kato, Ken
    Osumi, Hiroki
    Niihara, Masahiro
    Abe, Tetsuya
    Takemura, Ryo
    Hirata, Kenro
    Hamamoto, Yasuo
    Kawakubo, Hirofumi
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [9] Neoadjuvant sintilimab combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma (ESCC): Preliminary results from a phase II study.
    Guo, Jincheng
    Qiao, Chengrui
    Lu, Jiabin
    Yang, Shiqing
    Zhang, Boyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16008 - E16008
  • [10] Envafolimab plus chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study
    Zhao, Jinbo
    Yan, Xiaolong
    Bai, Yuquan
    Duan, Hongtao
    Jiang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345